END OF WXY,GET LONG FOR BOUNCE OF WAVE X OR NEW IMPULSE
AUROPHARMA COMPLETED DOUBLE CORRECTION WXY BY ACHIEVING THE EXTENTION TARGET FOR SECOND CORRECTION Y @ 938 AND HAS BOUNCED FROM THERE.
THERE WAS A POSITIVE RSI DIVERGENCE SIGNALLING END OF CORRECTION OR A MAJOR MOVE.
STOCK AFTER COMPLETING 7 SWING CORRECTION IS LOOKING GOOD FOR A DECENT BOUNCE TILL 1010 FROM CMP OF 970.
AS OF NOW ONE CAN GET LONG CMP OF 970 WITH A SL OF 955 ON 30 MIN CLOSING CANDLE WITH AN UPSIDE TGT OF 988-1000-1010.
PS:BY THE TIME I FINISHED WRITING THIS POST PRICE MOVED UP TO 974,NEVER THE LESS ONE CAN STILL GO LONG BASED ON THE STRUCTURE BUT RISK SHUD BE MANAGED ACCORDINGLY.
DISCLAIMER:There is no guarantee of profits or no exceptions from losses. The study provided is solely the personal views of my research. You are advised to rely on your judgment while investing/Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. Seek help of your financial advisors before investing/trading.
I may or may not trade this analysis
THERE WAS A POSITIVE RSI DIVERGENCE SIGNALLING END OF CORRECTION OR A MAJOR MOVE.
STOCK AFTER COMPLETING 7 SWING CORRECTION IS LOOKING GOOD FOR A DECENT BOUNCE TILL 1010 FROM CMP OF 970.
AS OF NOW ONE CAN GET LONG CMP OF 970 WITH A SL OF 955 ON 30 MIN CLOSING CANDLE WITH AN UPSIDE TGT OF 988-1000-1010.
PS:BY THE TIME I FINISHED WRITING THIS POST PRICE MOVED UP TO 974,NEVER THE LESS ONE CAN STILL GO LONG BASED ON THE STRUCTURE BUT RISK SHUD BE MANAGED ACCORDINGLY.
DISCLAIMER:There is no guarantee of profits or no exceptions from losses. The study provided is solely the personal views of my research. You are advised to rely on your judgment while investing/Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. Seek help of your financial advisors before investing/trading.
I may or may not trade this analysis
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.